Universiẗat, Diss.--Heidelberg, 2003.

A thesis submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg / Throughout the world, many traditional plant treatments for diabetes exist and therein lies a hidden wealth of potentially useful natural products for diabetes contrl. Despite this, few traditional antidiabetic plants have received scientific or medical scrutiny, and the World Health Organisation ( 1980 ) recommended accordingly that this area warrants further evaluation. / IT2018

A dissertation submitted in partial compliance with the requirements for the Master's Degree in Technology: Chiropractic, Durban Institute of Technology, 2006. / To determine the efficacy of the Harpago and celery seed cream in mild to moderate degenerative joint disease of the knee in terms of subjective and objective clinical findings / M

Philosophiae Doctor - PhD / The skin is the largest and most readily accessible organ of the body. The stratum corneum forms the outermost layer of the skin, which functions as a barrier to the external environment and regulates the passage of molecules across the skin. Drug delivery across the skin offers advantages over other routes of administration, bypassing the hepatic first pass metabolism, maintaining therapeutically effective drug levels, and improved patient compliance. Currently, there is a strong trend in the use of plant materials and extracts for medicinal purposes. Devil’s Claw (Harpagophytum procumbens) is a medicinal plant located in many regions throughout Southern and South Africa. It is used for its anti-inflammatory and analgesic properties with the harpagoside and harpagide components present reported to be responsible for these properties. Its activity has been reported to be as a result of the direct and indirect inhibition of Cyclooxygenase- 2 enzyme (COX-2). Efforts to improve the permeation of synthetic conventional compounds are constantly investigated, and great improvements of these formulations have led to very effective formulation of transdermal dosage forms such as anti-inflammatory drugs. The same should be possible for medicinal plants. Optimal permeation across the skin requires a drug to possess lipophilic as well as hydrophilic properties. Research suggests that a drug should have an aqueous solubility of more than 1 mg/ml and an octanol-water partition coefficient (log P) between 1 and 2 to optimally penetrate the skin (higher values indicating increased lipophilicity). Compounds not possessing these characteristics may be facilitated across the skin by the introduction of permeation enhancers in the formulation that include Azone® and sodium dodecyl sulphate xvi (SDS). The main aims of this study were to make an extract of Harpagophytum procumbens and to determine the direct COX-2 inhibition activity of this extract and further to formulate this extract into a pharmaceutical gel, with permeation enhancers that maintains its COX-2 enzyme inhibition qualities after transdermal penetration. The analytical techniques verified the existence of a harpagide and harpagoside components in the crude Harpagophytum procumbens extract and they were quantified in the extract at 3% and 1% respectively. COX-2 inhibition by the Harpagophytum procumbens extract was determined by a direct enzyme inhibition study and quantified by means of measuring the production of the product formed by the enzyme over a time interval in the presence of excess enzyme substrate. Crude Harpagophytum procumbens extract demonstrated a greater COX-2 enzyme inhibition than pure harpagide and harpagoside individually and combined. This indicated the existence of compounds in the extract contributing to this synergistic effect. This was reflected in the IC50 values indicating that the Harpagophytum procumbens crude extract had the lowest IC50 values concentration when compared to the harpagide and harpagoside. Octanol-PBS partition coefficient (log D) experiments were performed with various permeation enhancers and gels with varying combinations in order to determine the changing partitioning properties of harpagide and harpagoside. The octanol-PBS partition coefficient (log D) experiments indicated that harpagoside had a higher log D value than harpagide. The addition of permeation enhancers resulted in changes in the partition co-efficient of the marker compounds. The permeation enhancer, Azone®, resulted in the smallest reduction of Log D for harpagoside and the largest increase in Log D compared to other permeation enhancers tested for harpagide. xvii When the 2 marker compounds were formulated into different gel formulations (hydroxypropyl cellulose, Carbopol Ultrez 21® and Pluronic®), harpagide had the largest increase in Log D with the Carbopol Ultrez 21® gel. Harpagoside had the largest increase in the hydroxypropyl cellulose gel.Combinations of gel formulations with permeation enhancers were tested. The 2 best performing permeation enhancers in hydroxypropyl cellulose gel were SDS and Azone®. These compounds resulted in the largest increase in lipophilic partitioning for harpagide and harpagoside compound and higher values were achieved with SDS. Following the partition co-efficient determination, permeation studies with synthetic membranes were performed with the selected enhancer/gel formulations using Franz diffusional cells. The permeation (flux) across the hydrophobic synthetic membrane (Sil-Tec®) indicated flux of 27.1μg.cm-2.h-1 for harpagoside and 156.0 μg.cm-2.h-1 for harpagide in the hydroxypropyl cellulose gel. Incorporation of Azone® in the hydroxypropyl cellulose formulation resulted in an enhancement ratio (ER) of 14 for harpagoside. The hydroxypropyl cellulose gel with the permeation enhancers (Azone® and SDS) did not result in enhancement of permeation of the harpagide. Permeation of harpagoside and harpagide across the hydrophilic synthetic membrane (Tuffyrn®) yielded flux values of 537.1 μg.cm-2.h-1 and 101.1μg.cm-2.h-1 respectively in the Gel formulations. The Gel formulation containing Azone® and SDS, resulted in similar flux across this membrane compared to the formulation consisting of the Gel only, with the Azone® containing formulation resulting in lower flux for harpagide. Transdermal permeation was measured through excised female human abdominal skin using Franz diffusion cells. xviii Flux values for harpagoside and harpagide were 18.4 μg.cm-2.h-1 and 5.0 μg.cm-2.h-1 respectively when the crude extract was in the hydroxypropyl cellulose gel tested on human skin. Formulation of the crude extract in hydroxypropyl cellulose gel including Azone® and SDS permeation enhancers resulted in enhancement of 8 and 7 respectively for harpagide. Azone® increased the flux of harpagoside 14 times in the same hydroxypropyl cellulose gel formulation. The SDS had very little effect. The enhancement ratios achieved with the human skin was higher than that of the synthetic membranes. Post transdermal COX-2 inhibition activity studies were performed with the Azone® Gel formulation after it permeated across the human skin membrane to determine to what extent inhibitory activity of the crude extract was maintained. The crude drug retained its direct COX-2 inhibitory activity after permeation across the human skin with 77% inhibitory activity.

Made available in DSpace on 2016-08-17T18:39:50Z (GMT). No. of bitstreams: 1 6020.pdf: 1682477 bytes, checksum: 5dd37051fd1570e2897bd8af550c27c3 (MD5) Previous issue date: 2014-05-29 / Financiadora de Estudos e Projetos / Salmonellosis is an illness caused by bacteria of the genus Salmonella, a leading infectious disease worldwide. Due to the importance of this infection forward to eating habits, the search for a new compound that can contribute to current therapy against intestinal inflammation caused by Salmonellosis is of great value. The goal of this research was evaluate of this treatment effect with extract of Harpagophytum procumbens ( Hp ) in murine intestinal salmonellosis . In this research were realized counting of total cells and differential cell ( leukocytes, neutrophils and mononuclear cells) , dosages of cytokines (TNF- α , IL-12 , IL-10 and IL-4 ) and histopathological analysis of the liver and small intestine, at third and seventh day after the infection on animals treated with Hp and with animals didn t treated with. The animals were divided in: infected ( SE ) , infected and treated with Hp ( SE + HP ) and control group( C ). Balb / c mice ( female) were infected ( v.o ) with S. Enteritidis ATCC 13076 ( 1x108 UFC - 100 mL / animal) . The SE + HP group was treated with 150 mg / animal daily with Hp . The pathology of the liver and small intestine was prepared and stained with HE. Our results showed that there was an increase of leukocytes, specifically mononuclear cells analyzed in different compartments ( blood and CSF ), increased neutrophils in the blood in animals infected with SE on day 7 after infection. However, treatment with Hp was able to down modulate the recruitment of mononuclear cells on day 7 into the peritoneal cavity and negatively modulates the number of neutrophils in the same period. The levels of TNF-α showed a decrease on day 7 after treatment with Hp, suggesting a biological effect - down regulation - the inflammatory process in these animals . Furthermore, we also observed that animals treated with Hp infected with SE had a reduction in the number of neutrophils and mononuclear cells in the blood and decrease of IL -12. The production of IL-4 showed an increase in the + SE group HP suggesting that animals infected with S. Enteretidis and treated with H. procumbens appears to favor a microenvironment that directs the immune response profile of Th2 to Th1, whereas IL- 12 showed a decrease. IL- 10 has important regulatory effects on immunological and inflammatory responses mediated predominantly by macrophages. Our results show an increase of IL-10 in animals infected with SE, and this increase seems to be related to the severity of salmonellosis. Treatment with Hp stimulated inhibitory activity of IL - 10, favoring slight inhibition of the inflammatory process, on day 7 after infection. In the histopathological analysis of the liver observed that there was no difference between the groups, suggesting a local infection, since the blood culture was negative, carrying no systemic infection. In the small intestine was observed after 72 h in the SE group discrete wrinkle this epithelium, suggesting the invasion of S. Enteritidis, which was also observed hypertrophy of the wall of the villi and mild inflammatory infiltrate. In animals that received treatment with Hp hypertrophy was reduced with preservation of the villi of the intestinal architecture 7 days after infection. Thus, we suggest a possible role of Hp in modulating immune factors involved in the recruitment of inflammatory cells in the intestine of animals infected with SE, favoring discrete modulation of the inflammatory process in this model. / A Salmonelose é uma doença causada pela bactéria entérica do gênero Salmonella, uma das principais doenças infecciosas em todo o mundo. Devido à importância dessa infecção frente aos hábitos alimentares, a busca de um novo composto que possa contribuir com a terapia atual contra a inflamação intestinal causada pela Salmonelose é de grande valia. Assim, este estudo teve como objetivo avaliar os efeitos do tratamento com o extrato etanólico da Harpagophytum procumbens (Hp) na salmonelose intestinal murina. Neste estudo foram realizadas contagens das células totais e diferenciais (leucócitos, neutrófilos e células mononucleares), dosagem de citocinas (TNF-α, IL-12, IL-10 e IL-4) e analise histopatológica do fígado e intestino delgado ( 3º e 7º dia após a infecção) em animais tratados ou não com Hp. Os animais foram divididos em grupos: somente infectado (SE), infectado e tratado com Hp (SE+HP) e controle (C). Camundongos Balb/c (fêmeas) foram infectados (v.o.) com S. Enteritidis ATCC 13076 (1x108 UFC 100 μL/animal). O grupo SE+HP foi tratado com 150 μg/animal com Hp diariamente. O anatomopatológico do fígado e intestino delgado foi preparado e corado com HE. Nossos achados mostraram que, houve aumento de leucócitos, especificamente células mononucleares nos diferentes compartimentos analisados (sangue e LPC), aumento de neutrófilos no sangue nos animais infectados com SE no 7º dia após infecção. Entretanto, o tratamento com Hp foi capaz de modular negativamente o recrutamento de células mononucleares no 7º dia para a cavidade peritoneal e modulou negativamente o numero de neutrófilos no sangue no mesmo período. Os níveis de TNF-α apresentaram diminuição no 7º dia após tratamento com Hp, sugerindo um efeito biológico - down regulation - do processo inflamatório nesses animais. Além disso, observamos também que, animais tratados com Hp e infectados com SE tiveram redução no número de neutrófilos e células mononucleares no sangue e diminuição de IL-12. A produção de IL-4 apresentou aumento no grupo SE+HP sugerindo que animais infectados por S. Enteretidis e tratados com H. procumbens parece favorecer um microambiente que direcione o perfil da resposta imune de Th1 para Th2, visto que a IL-12 apresentou diminuição. A IL-10 tem efeitos regulatórios importantes sobre as respostas imunológicas e inflamatórias, sendo predominantemente mediada por macrófagos. Nossos resultados mostram aumento de IL-10 nos animais infectados com SE, e esse aumento parece estar relacionado com a gravidade da salmonelose. O tratamento com Hp estimulou atividade inibitória de IL-10, favorecendo discreta inibição do processo inflamatório, no 7º dia após a infecção. Nas analises histopatológicas do fígado observamos que, não houve diferença entre os grupos, sugerindo uma infecção local, visto que a hemocultura foi negativa, portando não houve infecção sistêmica. No intestino delgado observou após 72 h no grupo SE discreto enrugamento deste epitélio, o que sugere a invasão da S. Enteritidis, sendo observado também hipertrofia da parede das vilosidades e discreto infiltrado inflamatório. Nos animais que receberam tratamento com Hp houve uma redução da hipertrofia das vilosidades com preservação da arquitetura intestinal 7 dias após a infecção. Assim, sugerimos um possível papel da Hp em modular fatores imunológicos envolvidos no recrutamento de células inflamatórias no intestino de animais infectados com SE, favorecendo discreta modulação do processo inflamatório neste modelo.

OBJETIVO: O presente estudo avaliou o efeito dos extratos de H. procumbens e suas frações na atividade da COX-1 e COX-2 e produção de NO em ensaio de sangue total de voluntários sadios e pacientes com OA. MÉTODOS: A atividade da COX-1 foi determinada através da produção de TxB2 por plaquetas e da COX-2 pela produção de PGE2 por monócitos estimulados por LPS. A produção de NO2 -/NO3 - foi determinada por reação de Griess. Os ensaios in vitro foram realizados por incubação do extrato do extrato de H.procumbens e frações em sangue total. Os controles inibidores da atividade da COX-1 e COX-2 foram indometacina e etoricoxibe. A atividade enzimática das COXs e produção de NO foram avaliadas antes e após o tratamento com garra-dodiabo em pacientes com OA de coluna lombar. RESULTADOS: O tratamento com garra-do-diabo foi eficaz clinicamente e aumentou a atividade da COX-1 e COX-2 basal sem LPS. O extrato bruto do H. procumbens não alterou a atividade das COX. Entretanto, o harpagosideo inibiu a atividade da COX-1, COX-2 e a produção de NO. CONCLUSÃO: A garra-do-diabo mostrou-se eficaz no tratamento de pacientes com OA de coluna lombar. O harpagosideo deve ser alvo estudos específicos. / OBJECTIVE: The present study evaluated the effect of H. procumbens extracts and its fractions on COX-1 and COX-2 activity and NO production in whole blood assays of volunteers and OA patients. METHODS: The COX-1 and COX-2 activity was quantified as platelet TXB2 production in blood clotting and as PGE2 production in heparinized LPS-stimulated whole blood, respectively. Total NO2 -/NO3 - was determined by Griess reaction. In vitro assays were performed through incubation of the extract and fractions with whole blood from volunteers. Controls of the inhibition of COX-1 and COX-2 activity were indomethacin and etoricoxib. Before and after treating OA lumbar spine patients with devil\'s claw the COX-1 and COX-2 activity and NO production were evaluated in their whole blood. RESULTS: The treatment promoted clinical improvement and increase in the activity of COX-1 and basal COX-2, without LPS. The crude extract did not affect the activity of both enzymes. However, harpagoside inhibited COX-1 and COX-2 activity and NO production. CONCLUSION: Devil\'s claw promoted clinical improvement of OA patients and harpagoside must be focus of specific studies.

OBJETIVO: O presente estudo avaliou o efeito dos extratos de H. procumbens e suas frações na atividade da COX-1 e COX-2 e produção de NO em ensaio de sangue total de voluntários sadios e pacientes com OA. MÉTODOS: A atividade da COX-1 foi determinada através da produção de TxB2 por plaquetas e da COX-2 pela produção de PGE2 por monócitos estimulados por LPS. A produção de NO2 -/NO3 - foi determinada por reação de Griess. Os ensaios in vitro foram realizados por incubação do extrato do extrato de H.procumbens e frações em sangue total. Os controles inibidores da atividade da COX-1 e COX-2 foram indometacina e etoricoxibe. A atividade enzimática das COXs e produção de NO foram avaliadas antes e após o tratamento com garra-dodiabo em pacientes com OA de coluna lombar. RESULTADOS: O tratamento com garra-do-diabo foi eficaz clinicamente e aumentou a atividade da COX-1 e COX-2 basal sem LPS. O extrato bruto do H. procumbens não alterou a atividade das COX. Entretanto, o harpagosideo inibiu a atividade da COX-1, COX-2 e a produção de NO. CONCLUSÃO: A garra-do-diabo mostrou-se eficaz no tratamento de pacientes com OA de coluna lombar. O harpagosideo deve ser alvo estudos específicos. / OBJECTIVE: The present study evaluated the effect of H. procumbens extracts and its fractions on COX-1 and COX-2 activity and NO production in whole blood assays of volunteers and OA patients. METHODS: The COX-1 and COX-2 activity was quantified as platelet TXB2 production in blood clotting and as PGE2 production in heparinized LPS-stimulated whole blood, respectively. Total NO2 -/NO3 - was determined by Griess reaction. In vitro assays were performed through incubation of the extract and fractions with whole blood from volunteers. Controls of the inhibition of COX-1 and COX-2 activity were indomethacin and etoricoxib. Before and after treating OA lumbar spine patients with devil\'s claw the COX-1 and COX-2 activity and NO production were evaluated in their whole blood. RESULTS: The treatment promoted clinical improvement and increase in the activity of COX-1 and basal COX-2, without LPS. The crude extract did not affect the activity of both enzymes. However, harpagoside inhibited COX-1 and COX-2 activity and NO production. CONCLUSION: Devil\'s claw promoted clinical improvement of OA patients and harpagoside must be focus of specific studies.

Le cancer est une maladie multifactorielle dont la première étape est souvent une mutation. Il est envisageable de prévenir l'apparition de cette maladie en limitant l'apparition de mutations. Le benzo(a)pyrène et le 1-nitropyrène sont deux mutagènes et cancérogènes très répandus dans notre environnement. Ces deux composés entrainent une réponse inflammatoire chez l'homme qui à son tour induit un stress oxydant aboutissant à des mutations. L'objectif de cette étude est de rechercher l'activité antimutagène de sept plantes médicinales et de deux molécules naturelles anti-inflammatoires, avec un intérêt plus développé pour l'Harpagophytum procumbens (HP) et son principal iridoïde : l'harpagoside. Elle consiste également à vérifier si l'activité anti-inflammatoire peut être reliée à une activité antimutagène. L'activité antimutagène a été étudiée au niveau des mutations chromosomiques à l'aide du test des micronoyaux sur lymphocytes humains, et au niveau des mutations ponctuelles à l'aide du test d'Ames. Tous les extraits HP, à l'exception de l'extrait méthanolique, possèdent une activité antimutagène importante dans le test des micronoyaux, mais aucun dans le test d'Ames. Pour les six autres plantes anti-inflammatoires, plus de la moitié des extraits possèdent une activité antimutagène. Nous avons montré que l'activité antioxydante n'est pas ou peu impliquée dans l'activité antimutagène. Il est probable que d'autres mécanismes d'action soient impliqués tels que l'inhibition de l'inflammation (NF-ĸB). C'est la première fois que ce type d'études est réalisé sur des plantes possédant une activité anti-inflammatoire et plus particulièrement sur l' Harpagophytum procumbens. / Cancer is a multifactorial disease in which the first step is often a mutation in the genome. It is then possible to prevent the onset of the disease by limiting the occurrence of mutations. Benzo (a) pyrene (BaP) and 1-nitropyrene (1-NPY) are two widespread mutagens and carcinogens in our environment. These two compounds produce an inflammatory response in humans which in turn induces oxidative stress leading to gene mutations. The objective of this study was to investigate the antimutagenic activity of seven medicinal plants and two natural anti-inflammatory molecules, especially in Harpagophytum procumbens (HP) with its major iridoid: harpagoside. However, also to check whether the anti-inflammatory activity may be related to antimutagenic activity. The antimutagenic activity was investigated with chromosomal mutations using the in vitro cytokinesis-block micronucleus assay in primary cultures of human lymphocytes, and at the point mutations using the Ames test. All HP extracts, except for the methanol extract, showed a significant anti-mutagenic activity in the micronucleus test. No antimutagenic activity could be detected by the Ames assay. For the six other anti-inflammatory plants, more than half of the extracts possessed an antimutagenic activity. We have shown that the antioxidant property was not responsible for the antimutagenic activity. Thus, it is likely that other mechanisms of action are involved, such as anti-adduct mechanism, inhibition of metabolism or inhibition of inflammation (NF-ĸB). This is the first report of antimutagenic properties of anti-inflammatory plants and more particularly of the Harpagophytum procumbens.

Thesis (M.Tech.:Chiropractic) - Dept. of Chiropractic, Durban Institute of Technology, 2006 xvi, 82 leaves, Annexures A-L / To determine the efficacy of the Harpago and celery seed cream in mild to moderate degenerative joint disease of the knee in terms of subjective and objective clinical findings

Ce mémoire, consacré au développement de méthodes physico-chimiques pour le contrôle de la médication par l'Harpagophytum et l'Eleutherococcus, principes actifs utilisés en phytothérapie équine, est constitué de cinq chapitres. Le premier chapitre situe les enjeux des recherches entreprises ; il détaille le principe d'un contrôle de la méditation et le déroulement de celui-ci. Les propriétés, tant botaniques que pharmacologiques, des plantes étudiées, l'Harpagophytum procumbens et l'Eleutherococcus senticosus y sont également présentées. Dans le second chapitre, les différentes techniques expérimentales et les méthodes théoriques employées au cours de cette thèse sont détaillées. Cela concerne la préparation d'échantillon avec les différentes métho! des d'extraction, l'analyse par couplage chromatographie – spectrométrie de masse, et la modélisation moléculaire. Le troisième chapitre, dédié à l'étude de l'Harpagophytum, est présenté sur publications. L'extraction des principes actifs à partir des fluides biologiques équins, leur analyse par LC/MS, une approche théorique de la cationisation de l'harpagide par le sodium ainsi qu'une approche métabolique de l'harpagoside y sont développées. Une application directe de ces résultats à l'étude des éleutherocoques est présentée dans le chapitre 4, complétée par la recherche des principes actifs dans les compléments alimentaires. Le cinquième et dernier chapitre est un bilan des applications, des résultats et des perspectives qui découlent du travail effectué au cours de ces trois anné! es.